ZMC Completes Vitamin E Plant Upgrade

The upgraded operation has been constructed to address the growing attention to environmentally responsible manufacturing incorporating state of the art self-contained air and waste water treatment facilities.

Sep 9 2010 --- Zhejiang Medicine Company / Xinchang Pharmaceutical Co. Ltd. (ZMC) proudly announces the completion of the upgrade to its dl alpha tocopheryl acetate manufacturing facility.

Chunbo Li, Chairman, ZMC, stated “the completed upgrades to this manufacturing facility are resulting in a 98%+ assay product with consistently lower impurities, less color and more favorable viscosity than existing synthetic Vitamin E products.” Mr. Li further commented “The upgraded operation has been constructed to address the growing attention to environmentally responsible manufacturing incorporating state of the art self-contained air and waste water treatment facilities.”

Sander Krupski, National Sales Manager, ZMC-USA, reiterated “ZMC dl alpha tocopheryl acetate joins the growing list of products considered as superior quality and high value as produced by our parent company, ZMC. ZMC-USA stands ready for the opportunity to provide direct from the manufacturer representation for this product manufactured in one of the most ecologically state of the art synthetic Vitamin E plants.” Mr. Krupski added “ZMC-USA offers the only USP Ingredient Verified dl alpha tocopheryl acetate. This important third party endorsement assures the process as well as the product has been thoroughly audited to assure the highest quality and safety.”